Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002254
- Locations
- 🇺🇸
Johns Hopkins Hosp, Baltimore, Maryland, United States
🇺🇸Mem Sloan - Kettering Cancer Ctr, New York, New York, United States
🇺🇸Univ of North Carolina School of Medicine, Chapel Hill, North Carolina, United States
Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma
- Conditions
- Sarcoma, KaposiHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002259
- Locations
- 🇺🇸
Saint Luke's - Roosevelt Hosp Ctr, New York, New York, United States
A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome
- Conditions
- Pneumonia, Pneumocystis CariniiHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002002
- Locations
- 🇺🇸
San Francisco Gen Hosp, San Francisco, California, United States
Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas
- Conditions
- Lymphoma, Non-HodgkinHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002003
- Locations
- 🇺🇸
UMDNJ - New Jersy Med School, Newark, New Jersey, United States
🇺🇸New York Univ Med Ctr, New York, New York, United States
🇺🇸Saint Luke's - Roosevelt Hosp Ctr, New York, New York, United States
An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002271
- Locations
- 🇺🇸
Johns Hopkins Hosp, Baltimore, Maryland, United States
- Prev
- 1
- 2
- Next